Literature DB >> 10847494

Optical coherence tomography after laser photocoagulation for clinically significant macular edema.

M Rivellese1, A George, D Sulkes, E Reichel, C Puliafito.   

Abstract

BACKGROUND AND
OBJECTIVE: To demonstrate the utility of optical coherence tomography (OCT) for documenting an early response to laser photocoagulation in clinically significant macular edema (CSME) secondary to diabetes. PATIENTS AND METHODS: Five eyes of four patients were selected for review based on the diagnosis of CSME. All eyes had a clinical diagnosis of CSME based on slit lamp biomicroscopy. All eyes underwent focal/grid laser photocoagulation to areas of retinal thickening detected by OCT and clinical exam. Pre and post-treatment optical coherence tomograms were obtained for all patients.
RESULTS: All eyes selected for review had an early positive response to focal laser photocoagulation. OCT was useful for demonstrating areas of retinal thickening prior to laser treatment. Serial macular maps demonstrated the resolution of retinal thickening after laser photocoagulation in all eyes.
CONCLUSION: OCT is a useful tool for evaluating and documenting CSME both before and after focal/grid laser photocoagulation. OCT is capable of detecting an early positive response to photocoagulation for macular edema.

Entities:  

Mesh:

Year:  2000        PMID: 10847494

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  12 in total

1.  Visual acuity and perimetry as measures of visual function in diabetic macular oedema.

Authors:  E Agardh; H Stjernquist; A Heijl; B Bengtsson
Journal:  Diabetologia       Date:  2005-12-10       Impact factor: 10.122

2.  Is laser photocoagulation still effective in diabetic macular edema? Assessment with optical coherence tomography in Nepal.

Authors:  Arjun Shrestha; Deepak Khadka; Angira Karmacharya; Nhukesh Maharjan; Anand Shrestha; Raba Thapa; Govinda Poudyal
Journal:  Int J Ophthalmol       Date:  2012-04-18       Impact factor: 1.779

3.  Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema.

Authors:  Masahiko Shimura; Toru Nakazawa; Kanako Yasuda; Takashi Shiono; Kohji Nishida
Journal:  Br J Ophthalmol       Date:  2006-10-31       Impact factor: 4.638

4.  [Diagnosis and follow-up of non-diabetic macular edema with optical coherence tomography (OCT)].

Authors:  A E Schneeberg; W Göbel
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.059

5.  Subthreshold micropulse diode laser treatment in diabetic macular oedema.

Authors:  M L Laursen; F Moeller; B Sander; A K Sjoelie
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

Review 6.  Diabetic retinopathy: intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema.

Authors:  Quresh Amir Mohamed; Emily C Fletcher; Miranda Buckle
Journal:  BMJ Clin Evid       Date:  2016-03-16

7.  Acute orbital effects of retrobulbar injection on optic nerve head topography.

Authors:  Y Akar; K C Apaydin; A Ozel
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

Review 8.  [Proliferative vitreoretinopathy (PVR) minimal: same, same but different. Characteristics and surgical treatment of PVR-associated macular pucker].

Authors:  L-O Hattenbach; S Grisanti; S G Priglinger; A Chronopoulos
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

9.  Panretinal-Photocoagulation before Pars Plana Vitrectomy Influences Vitreous Level of Interleukin-6 but not of Vascular Endothelial Growth Factor in Patients with Diabetic Retinopathy.

Authors:  Masahiko Shimura; Kanako Yasuda; Toru Nakazawa; Takashi Shiono; Kohji Nishida
Journal:  Int J Biomed Sci       Date:  2007-03

10.  Evaluation of optical coherence tomography findings in age-related macular degeneration: a reproducibility study of two independent reading centres.

Authors:  Markus Ritter; Julee Elledge; Christian Simader; Gabor G Deak; Thomas Benesch; Barbara A Blodi; Ursula M Schmidt-Erfurth
Journal:  Br J Ophthalmol       Date:  2010-08-30       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.